Catalyst
Slingshot members are tracking this event:
AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free Makena (hydroxyprogesterone caproate injection)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMAG | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Approval, Preservative Free Makena, Hydroxyprogesterone Caproate Injection
